Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer

Therapy regimen and methods to sensitize cancer cells treated with epigenetic therapy to PARP inhibitors in lung cancer

US Patent 10105383 · Granted Oct 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cancer therapy via a combination of epigenetic modulation and immune modulation2021
Predicting response to epigenetic drug therapy2020
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2019
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2019
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2019
DNA methylation markers and methods of use2019
Compositions and methods for detecting a neoplasia2019
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018
Therapy regimen and methods to sensitize cancer cells treated with epigenetic th2018